These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

173 related items for PubMed ID: 16822883

  • 1. Basic fibroblast growth factor controls migration in human mesenchymal stem cells.
    Schmidt A, Ladage D, Schinköthe T, Klausmann U, Ulrichs C, Klinz FJ, Brixius K, Arnhold S, Desai B, Mehlhorn U, Schwinger RH, Staib P, Addicks K, Bloch W.
    Stem Cells; 2006 Jul; 24(7):1750-8. PubMed ID: 16822883
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Differential gene expression associated with migration of mesenchymal stem cells to conditioned medium from tumor cells or bone marrow cells.
    Menon LG, Picinich S, Koneru R, Gao H, Lin SY, Koneru M, Mayer-Kuckuk P, Glod J, Banerjee D.
    Stem Cells; 2007 Feb; 25(2):520-8. PubMed ID: 17053212
    [Abstract] [Full Text] [Related]

  • 7. Breast cancer cell-derived fibroblast growth factor 2 and vascular endothelial growth factor are chemoattractants for bone marrow stromal stem cells.
    Ritter E, Perry A, Yu J, Wang T, Tang L, Bieberich E.
    Ann Surg; 2008 Feb; 247(2):310-4. PubMed ID: 18216538
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Impairment of endothelial cell differentiation from bone marrow-derived mesenchymal stem cells: new insight into the pathogenesis of systemic sclerosis.
    Cipriani P, Guiducci S, Miniati I, Cinelli M, Urbani S, Marrelli A, Dolo V, Pavan A, Saccardi R, Tyndall A, Giacomelli R, Cerinic MM.
    Arthritis Rheum; 2007 Jun; 56(6):1994-2004. PubMed ID: 17530639
    [Abstract] [Full Text] [Related]

  • 10. Basic fibroblast growth factor stimulates human keratinocyte motility by Rac activation.
    Sogabe Y, Abe M, Yokoyama Y, Ishikawa O.
    Wound Repair Regen; 2006 Jun; 14(4):457-62. PubMed ID: 16939574
    [Abstract] [Full Text] [Related]

  • 11. Migration of bone marrow-derived mesenchymal stem cells induced by tumor necrosis factor-alpha and its possible role in wound healing.
    Fu X, Han B, Cai S, Lei Y, Sun T, Sheng Z.
    Wound Repair Regen; 2009 Jun; 17(2):185-91. PubMed ID: 19320886
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Distribution and differentiation of mesenchymal stem cells in tumor tissue.
    Zhao HF, Chen J, Xu ZS, Zhang KQ.
    Chin Med J (Engl); 2009 Mar 20; 122(6):712-5. PubMed ID: 19323940
    [Abstract] [Full Text] [Related]

  • 14. Mesenchymal stem cells transmigrate over the endothelial barrier.
    Schmidt A, Ladage D, Steingen C, Brixius K, Schinköthe T, Klinz FJ, Schwinger RH, Mehlhorn U, Bloch W.
    Eur J Cell Biol; 2006 Nov 20; 85(11):1179-88. PubMed ID: 16824647
    [Abstract] [Full Text] [Related]

  • 15. Tumor necrosis factor-related apoptosis-inducing ligand promotes migration of human bone marrow multipotent stromal cells.
    Secchiero P, Melloni E, Corallini F, Beltrami AP, Alviano F, Milani D, D'Aurizio F, di Iasio MG, Cesselli D, Bagnara GP, Zauli G.
    Stem Cells; 2008 Nov 20; 26(11):2955-63. PubMed ID: 18772312
    [Abstract] [Full Text] [Related]

  • 16. Comparison of ex vivo expansion culture conditions of mesenchymal stem cells for human cell therapy.
    Pérez-Ilzarbe M, Díez-Campelo M, Aranda P, Tabera S, Lopez T, del Cañizo C, Merino J, Moreno C, Andreu EJ, Prósper F, Pérez-Simón JA.
    Transfusion; 2009 Sep 20; 49(9):1901-10. PubMed ID: 19497059
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. The in vitro migration capacity of human bone marrow mesenchymal stem cells: comparison of chemokine and growth factor chemotactic activities.
    Ponte AL, Marais E, Gallay N, Langonné A, Delorme B, Hérault O, Charbord P, Domenech J.
    Stem Cells; 2007 Jul 20; 25(7):1737-45. PubMed ID: 17395768
    [Abstract] [Full Text] [Related]

  • 19. Angiogenic effects of human multipotent stromal cell conditioned medium activate the PI3K-Akt pathway in hypoxic endothelial cells to inhibit apoptosis, increase survival, and stimulate angiogenesis.
    Hung SC, Pochampally RR, Chen SC, Hsu SC, Prockop DJ.
    Stem Cells; 2007 Sep 20; 25(9):2363-70. PubMed ID: 17540857
    [Abstract] [Full Text] [Related]

  • 20. BV2 enhanced the neurotrophic functions of mesenchymal stem cells after being stimulated with injured PC12.
    Luo X, Ge C, Ren Y, Zhou J, Li X, Yan R, Zhang C.
    Neuroimmunomodulation; 2009 Jan 20; 16(1):28-34. PubMed ID: 19077443
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.